chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On 05/01/2021 (over 11 weeks from second dose) I noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and oozed with a crusty cap.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On the 3rd day my left eyelid was itching and by the end of the day it was significantly swollen.; On 4th day injection site is just a small scab but eyelid is still significantly swollen.; This is a spontaneous report from a contactable consumer, the patient. A 65-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: EP7534) via an unspecified route of administration in the left arm on 15Mar2021 at 10:00 (at the age of 65-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, (over 11 weeks from second dose) the patient noticed the injection site had risen to a bump with a head on it like a big mosquito bite. This was not there previously. It itched significantly for 3 days and on an unknown date in 2021, it oozed with a crusty cap. On the 3rd day on an unknown date in 2021, her left eyelid was itching and by the end of the day it was significantly swollen. On 4th day, on an unknown date in 2021, injection site was just a small scab but eyelid was still significantly swollen. The patient has had no exposure to mosquitos or other biting insects, and the arm location was exactly where the second Pfizer shot was administered. The clinical outcome of the events bump with a head on it like a big mosquito bite, itched significantly for 3 days, oozed with a crusty cap, eyelid was itching and significantly swollen, injection site was just a small scab was unknown at the time of this report.   No follow-up attempts are needed. No further information is expected.
April 12-16 Injection site pain leading to generalized pain in left arm lasting several days and affecting sleep (5 days) April 13-15: extreme fatigue (3 days) April 13: fever (1 day) April 16: deafness/Tinnitus with occasional vertigo and echo (ongoing)
VACCINE GIVEN AFTER A TEMPERATURE EXCURSION COLLECTIVELY FOR 472 HOURS; INCORRECT PRODUCT STORAGE; This spontaneous report received from a health care professional concerned a 65 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1855190 expiry: 24-SEP-2022) dose was not reported, administered on 06-JUL-2022 for covid-19 prophylaxis. The drug was associated with Medication error. Age at time of vaccination 65 years old. No concomitant medications were reported. On 06-JUL-2022, the patient experienced vaccine given after a temperature excursion collectively for 472 hours, and incorrect product storage. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the vaccine given after a temperature excursion collectively for 472 hours and incorrect product storage was not reported. This report was non-serious. This case, from the same reporter is linked to 20220945899, 20220948245, 20220945831 and 20220945933.
Woke up in the night, had numbness in hand. Right hand, tingling of fingers and nausea.
I woke up the day after my shot with chills and fever. I had shortness of breath, felt weak and couldn't do my normal daily activities. I was sick for about 36 hours and couldn't eat and my blood pressure was high. I  took fluids and tydonol for three days and eventually started to feel better.
This spontaneous report as received from an other health professional refers to an unspecified number of patients of unknown demographics. On unknown dates, the patients were vaccinated with ROTATEQ lot # M025563 and lot# M040267, oral for prophylaxis. On unknown dates, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event is unknown. The reporter considered incorrect product storage to be not related to ROTATEQ. Additional information has been requested. Sender's Comments: US-009507513-1707USA007005: US-009507513-1707USA011012: US-009507513-1707USA011013: US-009507513-1707USA011015.
Pfizer BioNTech COVID-19 Vaccine EUA / Moderna COVID-19 Vaccine EUA: Patient presented on 9/16/2021 requesting second dose of Moderna Vaccine, with the first dose of Moderna vaccine administered on 8/19/2021. Further discussion with patient after administration of the Moderna dose of 9/16/2021, it was discovered that the patient received a Pfizer vaccine series on 1/23/2021 and 2/20/2021 from a different healthcare provider. Vaccine administrations verified in state database.
As I was compressing the plunge on the syringe, I noticed that there was no liquid in the syringe rather it was air. The syringes had been provided to me prefilled. I spoke to my supervisor and the patient and proceeded to immunize the patient in her left arm. She was monitored for 30 minutes. No adverse reactions occurred. Process was immediately changed to  prevent the issue.
Within 15-20 seconds of receiving the injection, my daughter who has NO history of seizures or health issues of any kind, , began having seizures. Her skin color becamee gray, her lips turned blue. The seizure last approximately 20 seconds and when she came out of it she was able to breathe but said her throat felt funny, scratchy, smaller - but she was still able to breathe. She was nauseous, head hurt and was very disoriented for approximately 20-30 minutes. The pharmacist called 911. 911 arrived and took her blood, did a multitude to tests which all came out ok. We opted not to take her to the hospital as she was breathing ok, and her color was returning.
About 5-7 days after receiving my booster, I started to experience brain fog, fatigue and I was tired but unable to sleep. I was given Zoloft and Klonopin, but I don't use it regularly. They tried to give me other medication, but I wouldn't take it because of how it makes me feel.
tingly, red, swollen, hot face/ears/neck started 48 hours after, got worse on day 3, same on day 4, a little better day 5
Persistent severe headache, daily. Unrelenting with migraine medication, preventative medication, treatment for allergies or sinus congestion. Minimally responsive to OTC pain relievers. Headache now lasting full 3 months. Has missed 2 months of school, only able to tolerate a couple hours per day
rash; shingles; This is a spontaneous report from a contactable consumer. A 53-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTEHC COVID-19 VACCINE, Batch/Lot number was not reported), Solution for injection, via an unspecified route of administration on 18Mar2021 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in Mar2021, the patient experienced rash and shingles. It was reported that, slight rash turned into shingles. The outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Dizziness, muscle aches, headache.  Continued through until present time (10/20/2009 6pm).
September 12 starting of shingles.  Aching, pain in area, burning,  needles where blisters forming.  September 21 new case of shingles formed on top of and above already out break of shingles. Aching, pain, burning, needles on  blisters. All on back of left  back side thigh.
I felt a little tired after taking the shot. At about 10pm, I developed severe shivering, teeth chattering, aches and pains,  The chills broke around 1am. My spouse had no symptoms; My cousin felt sore at the site of injection; My mother developed a hard red spot at the injection site.  The symptoms are similar, but worse than the the second shot I received for COVID.
Fever/chills, weakness, fatigue, headache, arm pain and muscle aches.
The site of injection bled for a second and then swelled immediately; The side of injection was also very red, inflamed and swollen; The site of injection bled for and then swelled immediately/ The side of injection was also very red, inflamed and and swollen; The side of injection was also very red, inflamed and and swollen; This spontaneous case  was received on 28-Sep-2020 from pharmacist via agency (reference number: SEQW20-02452) and concerned 57-year-old male patient.  The patient's medical history and concomitant medications were not reported.  On 28-Sep-2020, the patient was vaccinated with Afluria Quadrivalent (influenza vaccine; dose: 0.5 ml; route of administration: intramuscular; anatomical location: not reported) for influenza prophylaxis. The batch number reported was P100253284 and expiry date 03-Jun-2021.  On the same day, immediately after receiving Afluria Quadrivalent the site of injection bled for a second and then swelled. The side of injection was also very red, inflamed and swollen for a while. Pharmacist used alcohol swabs and cotton balls to stop the bleeding, massaged a little bit, and put a band aid on it. It got better for a little while, but soon after it started swelling again and stayed swollen, red and large.  On the same day the patient recovered from the event of 'vaccination site bleeding'.   At the time of initial reporting on 28-Sep-2020, the patient had not recovered from the events 'vaccination site inflammation', 'vaccination site swelling' and 'vaccination site erythema'.  The reporter assessed the events as non-serious.   The reporter did not provide a causality assessment.  Company comment: Vaccination site reactions: haemorrhage, inflammation, swelling and erythema were associated with the use of the suspect product Afluria Quadrivalent. The events occurred immediately after vaccination making chronology highly suggestive. The patient's medical history and concomitant medications were not reported. With information presented, causality is assessed as possibly related for all events.; Sender's Comments: Vaccination site reactions: haemorrhage, inflammation, swelling and erythema were associated with the use of the suspect product Afluria Quadrivalent. The events occurred immediately after vaccination making chronology highly suggestive. The patient's medical history and concomitant medications were not reported. With information presented, causality is assessed as possibly related for all events.
Received Dtap and Hep A in right thigh on 2/25/08.  Mother called 2/26/08 stated that swelling in leg since last night.  Examined in clinic right anterior thigh with erythema, edema, warmth.  Treated for cellulitis with Bactrim 40/200/5ml 1 1/2 tsp bid x 10 days.  Mother states swelling redness resolved in 3 days.
Headache & Myalgia  Narrative:  missed one day of work following second dose  Other Relevant History:
BAD MUSCLE SPASMS; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 14-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On an unspecified date, the subject experienced bad muscle spasms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from bad muscle spasms. This report was non-serious.; Sender's Comments: V0: Medical assessment comment not required as per standard procedure since case was assessed as non serious.
On 3/7/2021 the patient presented to the ED with generalized weakness and altered mental status. She was admitted for hyponatremia and found to have a UTI. Per EUA, all hospitalization must be reported after receiving a vaccine. This hospitalization does not appear to be related to the vaccine.
Erythema and mild swelling to area surrounding injection sites. 7x7 cm. area surrounding TdaP site, 10x8 cm area surrounding Menactra site.
I am unsure of the exact vaccination. However the next day, I went to touch my granddaughter's arm and it felt warm. upon removing her shirt, it was noted that her left upper arm and bicep was almost twice the size of her other arm, very warm to the touch, and she was running a low grade fever. My daughter (her mother) called the office right away and a nurse came back and said, "it is a local reaction", treat it with warm compresses and tylenol. I had taken a picture of it and sent it to my daughter, who then tried calling back and no one answered (this of course a Friday afternoon). We contemplated taking her to the ER, however, the news was reporting to stay away if possible due to the flu outbreak. She was seen the following day by the pediatrician. This doctor called it a "local" reaction. However, I have given immunizations for 3 years and never saw one like this!
Reported by pt's spouse: Pt. took last oral typh. capsule 1/13/11; on 1/14/11 pt c/o numbness right leg initially progressing to numbness both legs and from waist down and unable to walk.  Pt. took first dose oral typhoid 1/7/11.
10/9/2021 Hospitalized with cough, hypoxia, weakness, SOB. Initially treated with oxygen, dexamethasone and respiratory treatments.  Died. Primary cause: ACUTE ON CHRONIC RESPIRATORY FAILURE WITH HYPOXIA 10/9-10/24/21 Due to or consequence of:  COVID-19 PNEUMONIA 10/9-10/24/21, ACUTE CHF EXACERBATION 10/9-10/24/21 COPD EXACERBATION
arm was a little sore; lymph nodes in my neck and armpit were swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 34 year-old female patient (not pregnant) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "High Blood Pressure" (unspecified if ongoing), notes: High Blood Pressure; "Known allergies: Sulfa" (unspecified if ongoing), notes: Known allergies: Sulfa; "Known allergies: Penicillian" (unspecified if ongoing); "Known allergies: Shell fish" (unspecified if ongoing). Concomitant medication(s) included: VITAMIN D [COLECALCIFEROL]; VIT B12; CITALOPRAM; LOSARTAN POTASSIUM. Vaccination history included: Bnt162b2 (Dose Number: 1, Location of injection: Arm Left), for COVID-19 Immunization, reaction(s): "tired". The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "recovered", described as "arm was a little sore"; LYMPHADENOPATHY (non-serious), outcome "recovered", described as "lymph nodes in my neck and armpit were swollen". Therapeutic measures were not taken as a result of pain in extremity, lymphadenopathy.  Additional information: The most recent COVID-19 vaccine was administered at Vaccination Site. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not been tested for COVID-19.   Follow-up attempts are completed. No further information is expected.
Left leg pain, neck pain, numbness on leg pain during night time. Daily headache. I was diagnosed with chronic headaches and taking medication from it, but after the shot, it getting worse even my medicines not helping with it. Cannot concentrate on my work. After the shot, I had chills, fever, fatigue, and muscle pain. But symptoms such as leg pain, neck, and headaches still bothering me.
About 3 months after receiving the shot the patient began experiencing extreme back pain and was ultimately diagnosed with a rare and aggressive CNS Lymphoma.  She passed away on April 6th.
vaccine that were drawn up on 2Jul2021 were given on 6Jul2021; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine that were drawn up on 2Jul2021 were given on 6Jul2021) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine that were drawn up on 2Jul2021 were given on 6Jul2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (vaccine that were drawn up on 2Jul2021 were given on 6Jul2021) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment drug details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Fallow-up received and contains no new information.
Varicella - Information has been received from a health care professional concerning a 9 year old caucasian male patient who on 19 Sep 1997 was vaccinated in the left arm with a first dose of varicella virus vaccine live (lot 623555/0691E.  There were no concomitant medications, allergies or past medical history.  On 26 Apr 2000 the patient experienced a mild form of chicken pox.  On an unspecified date the patient recovered.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 44-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Dec2022 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 44 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Diabetic" (unspecified if ongoing); "thyroid issues" (unspecified if ongoing), notes: thyroid issues; "obesity" (unspecified if ongoing); "chronic pain" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Lyrica, reaction(s): "Known allergies: Lyrica", notes: Known allergies: Lyrica; Gabapentin, reaction(s): "Known allergies: Gabapentin", notes: Known allergies: Gabapentin; Bisoprol, reaction(s): "Known allergies: Bisoprol", notes: Known allergies: Bisoprol; Lisinopril, reaction(s): "Known allergies: Lisinopril", notes: Known allergies: Lisinopril; Salmeterol inhaler, reaction(s): "Known allergies: Salmeterol inhaler", notes: Known allergies: Salmeterol inhaler. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Feb2023, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
My menstrual cycle started the day after the first shot (and my flow was completely different than normal) and again the day after the second shot. Both times were very, very unexpected and not at the appropriate time.
positive COVID-19 test; positive COVID-19 test; positive COVID-19 test; This is a spontaneous report from a contactable pharmacist. A around 50-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 22Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The physician reported that he knew the patient got the vaccine on 22Dec2020. On 02Jan2021, he tested positive to COVID-19. The outcome of the events was unknown.  Information on the Lot/batch number has been requested.; Sender's Comments: The association between the event lack of effect (tested positive for COVID-19) with BNT162b2 can not be completely excluded.
Given per Fire Department on outreach to homebound. Approximately 1/4 of vaccine solution dose lost from needle hub while being injected into patient's muscle.
Moderna had more side effects than the Pfizer one; Got really bad chills; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Moderna had more side effects than the Pfizer one) and CHILLS (Got really bad chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Moderna had more side effects than the Pfizer one) and CHILLS (Got really bad chills). At the time of the report, VACCINATION COMPLICATION (Moderna had more side effects than the Pfizer one) and CHILLS (Got really bad chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication was not reported.  On an unknow date, patient got really bad chills after receiving Moderna vaccine. It seems like Moderna had more side effects than the Pfizer one. Treatment details were not reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
meets criteria for vaccine break through. EE vaccinated 12/30/20 and 1/20/21 with Pfizer covid vaccine but symptomatic 3/15/21 with positive test 3/17/21
Severe Chills/Sweats began on 02/18/2021 at approximately 02:00 AM Began having stomach pains in the early morning hours on 02/19/2021 (Approximately 04:00 AM) before vomiting. Went to the hospital later in the morning and was rushed into surgery for appendicitis.
abnormal Hb ss ag  8 days after immunization for covid 19 on 3/18/21
RED RASG ITCHING SORE ARM FOR 3 DAYS  Narrative:
After getting my first Pfizer shot, a week-two later I started experiencing tingling/numbness in my whole left arm, left leg and occasionally my right leg. Thought I was potentially having a heart attack/stroke. Saw my primary care Dr. Did bloodwork and EKG. Everything came back fine. Eventually developed Lhermitte's Sign the following week of April 26th.  Had brain scan the following week, seemed relatively normal. After finally seeing a Neurologist in June, in July I was diagnosed with MS through a spine MRI which showed one new lesion. Was not presenting any MS symptoms previously to the vaccine. Mentioned this in the follow up the CDC provides, however, was never able to make true phone contact to notify.